Evania 25 mg (Tablet)

Unit Price: ৳ 45.00 (2 x 6: ৳ 540.00)

Strip Price: ৳ 270.00

Medicine Details

Category	Details
Generic	Empagliflozin
Company	Healthcare pharmaceuticals ltd
Also available as	Evania 10 mg tablet

Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
To reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease

Sodium glucose co-transporter-2 (SGLT-2) inhibitor

Recommended dose of 10 mg once daily, may be increased to 25 mg once daily in patients tolerating the medication

Co-administration with diuretics resulted in increased urine volume
Co-administration with insulin or insulin secretagogues increases the risk for hypoglycemia
Monitoring glycemic control with urine glucose tests is not recommended
Monitoring glycemic control with 1,5-anhydroglucitol (1,5-AG) assay is not recommended

History of serious hypersensitivity reaction to the medication, severe renal impairment, end-stage renal disease, or dialysis

Not enough data available for pregnant women, not recommended during breastfeeding

Assessment of renal function is recommended prior to initiation of the medication

Supportive measures should be employed in the event of an overdose

Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors

Keep in a cool & dry place (below 30°C), protected from light & moisture

Molecular Formula: C23H27ClO7
Chemical Structure Image: https://medex.com.bd/storage/res/g-res-1275-empagliflozin-chemical-structure-Z3X0mrA6UvgM682Jgp8K.svg

Used to improve glycemic control in adults
Unsafe to use during pregnancy
Unsafe to use during breastfeeding
Should be used cautiously in patients with underlying kidney disease
No dose adjustment needed for patients with mild to moderate liver disease
Can cause dehydration and hypoglycemia
Should be monitored regularly and prompt medical attention if experiencing specific symptoms